Recursion Pharmaceuticals...
6.61
0.29 (4.59%)
At close: Jan 15, 2025, 11:07 AM

Recursion Pharmaceuticals Inc. Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for RXRX stock have an median target of 9, with a low estimate of 6 and a high estimate of 11. The median target predicts an increase of 36.16% from the current stock price of 6.61.

Analyst Consensus: Hold
Target Low Average Median High
Price $6 $8.75 $9 $11
Change -9.23% 32.38% 36.16% 66.41%

AI Analyst Report

Needham has reiterated a Buy rating on Recursion P... Unlock content with Pro Subscription

Updated Dec 11, 2024

Rating Jul 24Aug 24Sep 24Nov 24Dec 24Jan 25
Strong Buy 000000
Buy 111211
Hold 002000
Sell 000000
Strong Sell 000000
Total 1 1 3 2 1 1

Financial Forecast this Year

Revenue This Year
64.72M
from 44.58M
Increased by 45.2%
Revenue Next Year
79.40M
from 64.72M
Increased by 22.7%
EPS This Year
-1.53
from -1.58
Increased by 3.2%
EPS Next Year
-1.64
from -1.53
Increased by -7.2%